Favorable Gleason 3Â + 4 Prostate Cancer Shows Comparable Outcomes With Gleason 3Â + 3 Prostate Cancer: Implications for the Expansion of Selection Criteria for Active Surveillance

Despite the application of low-risk criteria, GS 3 + 4 PCa patients showed significantly worse outcomes than GS 3 + 3 patients. However, favorable GS 3 + 4 patients showed comparable clinicopathologic outcomes with GS 3 + 3 patients, suggesting possible expansion of AS for the favorable GS 3 + 4 group.